Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005176 · ClinicalTrials.gov registry record
Long QT Syndrome-Population Genetics and Cardiac Studies
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 2,125
- Enrollment target
NCT00005176: Completed study, sponsored by University of Rochester.
NCT00005176 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 2,125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005176 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 2,125 participants
- Enrollment target
Study Summary
To investigate the clinical, genetic and cardiologic aspects of the Long QT Syndrome, a predominantly hereditary disease with episodic malignant arrhythmias and sudden death, and a demonstrated gene linkage in a large pedigree.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,125 participants |
| Start Date | 1985-08 |
| Est. Completion | 2013-04 |
What the finished NCT00005176 record still lists
NCT00005176 is an observational study that tracks outcomes without assigning an intervention. Its 2,125 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00005176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005176 about?
NCT00005176 is a clinical study titled "Long QT Syndrome-Population Genetics and Cardiac Studies". To investigate the clinical, genetic and cardiologic aspects of the Long QT Syndrome, a predominantly hereditary disease with episodic malignant arrhythmias and sudden death, and a demonstrated gene linkage in a large pedigree.
What is the current status of trial NCT00005176?
This trial is currently completed. The enrollment target is 2,125 participants. The study started on 1985-08. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT00005176?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05681624 · 2,124 participants · NA
Maternal Oxygen Supplementation for Intrauterine Resuscitation
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- NCT05916430 · 2,120 participants
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
- NCT05650658 · 2,136 participants · NA
Left vs Left Randomized Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia